The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
VEGF-A Is Necessary and Sufficient for Retinal Neuroprotection in Models of Experimental Glaucoma
Open accessAbstract
Vascular endothelial growth factor A (VEGF-A) is a validated therapeutic target in several angiogenic- and vascular permeability-related pathological conditions, including certain cancers and potentially blinding diseases, such as age-related macular degeneration and diabetic retinopathy. We and others have shown that VEGF-A also plays an important role in neuronal development and neuroprotection, including in the neural retina. Antagonism of VEGF-A function might therefore present a risk to neuronal survival as a significant adverse effect. Herein, we demonstrate that VEGF-A acts directly on retinal ganglion cells (RGCs) to promote survival. VEGF receptor-2 signaling via the phosphoinositide-3-kinase/Akt pathway was required for the survival response in isolated RGCs. These results were confirmed in animal models of staurosporine-induced RGC death and experimental hypertensive glaucoma. Importantly, we observed that VEGF-A blockade significantly exacerbated neuronal cell death in the hypertensive glaucoma model. Our findings highlight the need to better define the risks associated with use of VEGF-A antagonists in the ocular setting.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Common mechanisms of nerve and blood vessel wiring
Carmeliet, P., & Tessier-Lavigne, M. (2005) · Nature · doi:10.1038/nature03875 · Cited by 1,085
Sondell, M., Lundborg, G., & Kanje, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-14-05731.1999 · Cited by 750 · cited 1×
“In vitro, VEGF-A can protect neurons against hypoxia, glutamate excitotoxicity, and deprivation of serum, oxygen, or glucose, and mediate neuronal migration, axonal outgrowth, and Schwann cell proliferation.(6,7) In vivo, VEGF-A can rescue retinal neurons after optic nerve axotomy,(8) protect neural tissues through hy…”
BackgroundDiverse roles for VEGF-A in the nervous system
Mackenzie, F., & Ruhrberg, C. (2012) · Development · doi:10.1242/dev.072348 · Cited by 294
Lifespan and mitochondrial control of neurodegeneration
Wright, A. F., Jacobson, S. G., Cideciyan, A. V., Roman, A. J., Shu, X., Vlachantoni, D., McInnes, R. R., & Riemersma, R. A. (2004) · Nature Genetics · doi:10.1038/ng1448 · Cited by 111 · cited 1×
“Lastly, although focused on inherited disease, experimental analyses suggest that the rate of neurodegeneration in rodents could be as much as two orders of magnitude greater than in humans, and is related to maximum lifespan potential.(54) Therefore, short-term rodent experiments may exaggerate the acute risks and lo…”
Background
Cited by
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Lange, C., Storkebaum, E., de Almodóvar, C. R., Dewerchin, M., & Carmeliet, P. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.88 · Cited by 382
Bhisitkul, R. B., Mendes, T. S., Rofagha, S., Enanoria, W., Boyer, D. S., Sadda, S. R., & Zhang, K. (2015) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2015.01.032 · Cited by 210
Neuroprotection in Glaucoma: Animal Models and Clinical Trials
Almasieh, M., & Levin, L. A. (2017) · Annual Review of Vision Science · doi:10.1146/annurev-vision-102016-061422 · Cited by 111
“…ability of various neuroprotective treatments to preserve RGCs and their function in animal models of glaucoma, including drugs (Chen et al. 2015, Foxton et al. 2013, Kimura et al. 2017, Salt et al. 2014, Stankowska et al. 2015, Van de Velde et al. 2015, White et al. 2015), immunotherapy (Russo…”
BackgroundMaguire, M. G., Liu, D., Glassman, A. R., Jampol, L. M., Johnson, C. A., Baker, C. W., Bressler, N. M., Gardner, T. W., Pieramici, D., Stockdale, C. R., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2019.5939 · Cited by 61
Yan, P., Tang, S., Zhang, H., Guo, Y., Zeng, Z., & Wen, Q. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9935-6 · Cited by 17
Metadata
- Authors
- Foxton, R. H., Finkelstein, A., Vijay, S., Dahlmann-Noor, A., Khaw, P. T., Morgan, J. E., Shima, D. T., & Ng, Y.-S.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2013-04
- Volume
- 182
- Issue
- 4
- Pages
- 1379-1390
- ISSN
- 0002-9440 (ISSN-L)
- OpenAlex
- W2104500335
- Cited by
- 191
- References
- 5
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.